Tag Archives: MC1982

JFOUND: O’Connor, Owen [MC1982] Co-Founder Therasis, Inc.

2015-Feb-21

http://www.bloomberg.com/research/stocks/private/person.asp?personId=32677349&privcapId=82661644&previousCapId=82661644&previousTitle=Therasis,%20Inc.

Owen A. O’Connor M.D., Ph.D.
Co-Founder and Director, Therasis, Inc.

Dr. Owen A. O’Connor, M.D., Ph.D. serves as Attending Physician in the Department of Medicine at Memorial Sloan Kettering Cancer Center in New York City, where Dr. O’Connor serves as the Head of the Laboratory of Experimental Therapeutics for the Lymphoproliferative Malignancies. He serves as an associate professor of medicine and a leader of the Lymphoid Development and Malignancy program at Columbia University Medical Center.

Dr. O’Connor co-founded Therasis, Inc. in 2007.

His research interests focus on the discovery and development of novel small molecules for the treatment of hematologic malignancies. Dr. O’Connor is an internationally recognized leader in the discovery and development of new drugs for the treatment of hematologic malignancies, in particular lymphoma.

To date his laboratory and clinical research efforts have led to the U.S. FDA approval of several drugs for the treatment of lymphoma, including the proteasome inhibitor bortezomib for the treatment of mantle cell lymphoma, the histone deacetylase inhibitor vorinostat for the treatment of cutaneous T-cell lymphoma (CTCL), and most recently pralatrexate, the first drug ever approved for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL).

Dr. O’Connor co-invented and developed pralatrexate at Memorial Sloan-Kettering Cancer Center, which became the first drug ever approved by the FDA for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.

He serves as Member of Scientific Advisory Board at Stemline Therapeutics, Inc.

He served as Member of Medical Advisory Board of Cornerstone Pharmaceuticals, Inc.

Dr. O’Connor went on to do a medical internship and residency at the New York Hospital-Cornell University Medical Center. Following his medical residency, he did a fellowship in Medical Oncology at the Memorial Sloan Kettering Cancer Center, and a Fellowship in Clinical Pharmacology at the New York Hospital-Cornell University Medical School. Dr. O’Connor received his B.S. in Biology, magna cum laude, from Manhattan College in 1982, his Ph.D. in Biochemical Toxicology and Chemical Carcinogenesis from NYU School of Medicine, and his M.D. from the University of Medicine & Dentistry of New Jersey-Robert Wood Johnson Medical School in 1994.

# – # – # – # – #  

O’Connor, Owen [MC1982]

# – # – # – # – #  2015-Feb-21 @ 12:30  

JLINKEDIN: DeSantis, Michael [MC1982] Senior Project Engineer at Red Hawk Fire & Security NY

2015-Feb-11

http://www.linkedin.com/pub/michael-desantis/15/837/29/en

DeSantis, Michael [MC1982]
Senior Project Engineer at Red Hawk Fire & Security NY
Greater New York City Area
Construction

# – # – # – # – # 

JNEWS: Brennan, Bob [MC1982] cybersecurity CEO

2015-Feb-03

http://upstart.bizjournals.com/entrepreneurs/hot-shots/2015/02/01/cyber-security-threats-dont-scare-bob-brennan.html?page=all

February 1, 2015, 12:00pm EST | Updated: February 2, 2015, 12:35pm EST
How a psychology degree helps this cybersecurity CEO understand people
Sara Castellanos    Technology Reporter    Boston Business Journal

*** begin quote ***

Tell me about your early life; where did you grow up?

I grew up in New York City in a working-class family. I went to Manhattan College in New York City majoring in psychology, and that was really about wanting to know what makes people tick and what drives human nature and motivation. I was really interested in psychology and philosophy and was otherwise not the most attentive student. I went into sales and found myself really struggling to have any passion around the product I was selling. I noticed a lot of companies were buying these things called word processors, and that was really transforming the secretary’s productivity. Before the PC was born and came into being around 1982, I started to get into computers.

*** end quote ***

Brennan, Bob [MC????]

# – # – # – # – # 

Dear John,

I believe that Bob is a member of the Class of 1982.

Mike

McEneney, Mike (MC1953)

[JR: Thanks, Mike. Much appreciated.]

Brennan, Bob [MC1982]

# – # – # – # – #  2015-Feb-03 @ 17:45  

JLINKEDIN: Sansone, Karen [MC1982] Executive Director at Pfizer

2015-Feb-03

http://www.linkedin.com/pub/karen-sansone/9/85/ab9/en

Sansone, Karen [MC1982]
Executive Director at Pfizer
Greater New York City Area
Pharmaceuticals

# – # – # – # – #  2015-Feb-03 @ 13:39  

 

JNEWS: Huvane, Stephen [MC1982] Eastchester St. Patrick’s Day Parade Honoree

2015-Feb-02

http://patch.com/new-york/bronxville/joe-houlihan-named-grand-marshall-eastchester-st-patricks-day-parade-2015

Joe Houlihan Named Grand Marshall of Eastchester St. Patrick’s Day Parade 2015
Honorees Stephen and Kathleen Huvane
By Harrison Edwards (Open Post) February 1, 2015 at 8:52am

*** begin quote ***

Stephen Huvane and Kathleen Huvane have been selected as Parade Honorees.

*** and ***

Stephen received his B.S. CIS from Manhattan College, M.S. from Iona College and currently works at Purdue Pharma L.P.

*** end quote ***

Huvane, Stephen [MC????]

# – # – # – # – #  2015-Feb-02 @ 17:06

Dear John,

I believe that Stephen is a member of the Class of 1982.

Mike

McEneney, Mike (MC1953)

[JR: Thanks, Mike. Much appreciated.]

Huvane, Stephen [MC1982]

# – # – # – # – #  2015-Feb-03 @ 11:20   

JFOUND: LaRochelle, William [MC1982] Roche 454 Sequencing Solutions

2015-Jan-27

http://www.bloomberg.com/research/stocks/private/person.asp?personId=118599481

LaRochelle, William [MC????]

Dr. William J. LaRochelle, Ph.D. serves as Head of Healthcare & Key Opinion Leader Management at Roche 454 Sequencing Solutions. He is also member of firm’s International Business Team. In addition, he is the Roche 454 global liaison to Genentech, Roche Pharma, Chugai and external key opinion leaders for Roche’s personalized healthcare strategy in cancer genomic medicine.

Dr. LaRochelle joined Roche 454 Sequencing Solutions from its former parent company, CuraGen Corporation, where he directed the Preclinical Drug Development Program. He previously directed the Translational Oncology Program at CuraGen. His group was responsible for using CuraGen’s genomics technologies to identify and validate drug targets within the fully human monoclonal antibody alliance with Amgen Fremont in concert with Seattle Genetic’s antibody drug conjugate technology.

Prior to joining CuraGen, Dr. LaRochelle was a principle investigator at the National Cancer Institute in the Laboratory of Cellular and Molecular Biology for over 13 years.

His academic research was focused on growth factor signal transduction and neutralizing antibodies in cancer and inflammation. He received an American Cancer Society Postdoctoral Fellowship to study oncogene signal transduction at the National Cancer Institute. Following his fellowship, Dr. LaRochelle assumed his appointments as staff fellow, senior staff fellow and finally principal investigator at the National Cancer Institute at the National Institutes of Health (NIH).

He is the author of over 80 peer-review publications and numerous patents, the editor of the Oncogenomics Handbook, and the recipient of multiple Federal Technology Transfer Awards. Dr. LaRochelle earned his degrees from Dartmouth Medical School (Ph.D. – Biochemistry) and Manhattan College (B.S. in Biochemistry).

# – # – # – # – # 

Dear John,       

I believe that William is a member of the Class of 1982.

Mike

McEneney, Mike (MC1953)

[JR: Thanks, Mike. Much appreciated.]

LaRochelle, William [MC1982]

# – # – # – # – # 

JNEWS: Dixon, James J. [MC1982] Chair of the Energy Committee

2014-Dec-10

http://www.electricenergyonline.com/detail_news.php?ID=509375&titre=Con+Edison+development%27s+James+J.+Dixon+elected+Chair+of+the+Association+of+Corporate+Counsel+Energy+Committee&cat=;54

Con Edison development’s James J. Dixon elected Chair of the Association of Corporate Counsel Energy Committee

December 10, 2014

James J. Dixon, vice president for legal and compliance services for ConEdison Development and ConEdison Energy, has been elected Chair of the Energy Committee of the Association of Corporate Counsel (ACC), a global bar association representing more than 35,000 in-house lawyers in 90 countries.

ACC promotes the common professional and business interests of the in-house bar through information, networking opportunities, advocacy initiatives and education, and sponsors 18 practice-area committees, including the ACC Energy Committee. The Committee focuses on raising awareness of corporate domestic and international energy law. The Committee also spearheads the development of energy-focused educational resources for in-house counsel.

As the ACC Energy Committee Chair, Mr. Dixon will develop and implement the Committee’s strategic plan, propose and organize energy-related programs for the 2015 ACC Annual Meeting in Boston, lead the development of written and broadcasted resources, and help oversee membership development.

ConEdison Development develops renewable and energy infrastructure assets, and ConEdison Energy is a wholesale energy company. Both are subsidiaries of Con Edison Inc.

Mr. Dixon previously served as Vice President of Energy Services for ConEdison Solutions, an energy services company that is also a Con Edison Inc. subsidiary.

“Jim Dixon has an outstanding reputation for his legal and practical experience in the energy industry,” said Craig Johnson, Deputy General Counsel for Energy & Transportation at Caterpillar. “At a time when energy companies face a range of new challenges, the Committee is certain to benefit from Jim’s wisdom, legal expertise and first-hand knowledge of key areas in this dynamic sector.”

“The energy industry is one of the most rapidly changing business sectors in America today,” said Mr. Dixon. “Organizations like ACC play a critical role in ensuring the effectiveness and efficiency of in-house counsel serving energy-related businesses. It is a privilege to be able to play a role in helping energy firms fortify their legal infrastructures.”

Before joining ConEdison Solutions, Mr. Dixon held positions at Con Edison Company of New York – the utility commonly known as “Con Ed” — as an electrical engineer in its construction, operations and design organizations. He was also an attorney in the company’s Nuclear Regulatory and Commercial Litigation Services sections, eventually becoming Assistant Corporate Secretary. Mr. Dixon also served as ConEdison Solutions’ first dedicated legal counsel.

He is a registered professional engineer in New York State and a retired major from the U.S. Army Reserve, where he commanded a Combat Heavy Engineer Company and was Executive Officer for an Engineer Battalion. Mr. Dixon is an honors graduate of both the basic and advanced officer courses at the United States Army Engineer School.

Mr. Dixon received a bachelor’s degree in electrical engineering from Manhattan College and a law degree from New York Law School. He is admitted to practice law in New York and Washington D.C. and is a member of the New York State Bar Association.

Mr. Dixon also served as Chairman of NAESCO, the National Association of Energy Service Companies, from 2010-2012 the leading energy services industry trade organization that promotes energy efficiency nationwide on behalf of more than 80 member companies.

For more information about the ACC Energy Committee, visit http://www.acc.com/committees/energy.

# – # – # – # – #   

Dixon, James J. [MC1982] 

# – # – # – # – #  2014-Dec-10 @ 18:45